Latest News about CYTK
Recent news which mentions CYTK
Cytokinetics Sets Stage For Mid-Stage Study For Heart Failure Drug After Encouraging Data From Phase 1 Study
September 09, 2024
From Benzinga
Tickers
CYTK
From InvestorPlace
7 Biotech Stocks to Boost Your Portfolio to Peak Health
June 26, 2024
From InvestorPlace
From InvestorPlace
From Benzinga
Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe
May 23, 2024
From Benzinga
From Benzinga
From Benzinga
Gold Falls Sharply; US Composite PMI Surges In May
May 23, 2024
From Benzinga
Why Cytokinetics (CYTK) Shares Are Falling
May 23, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Tickers
CYTK
From InvestorPlace
From InvestorPlace
3 Biotech Stocks to Buy on the Dip: April 2024
April 26, 2024
From InvestorPlace
From Benzinga
2 Incredible Growth Stocks to Buy Right Now
March 20, 2024
From Motley Fool
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
March 18, 2024
Tags
NASDAQ:TECH,NASDAQ:CNTA,NASDAQ:MDGL,NASDAQ:CYTK,NASDAQ:CPRX,NASDAQ:IOVA,NASDAQ:SLN
Stocks to Buy
Market News
From InvestorPlace
From Benzinga
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
March 13, 2024
From InvestorPlace
Unpacking the Latest Options Trading Trends in Cytokinetics
February 28, 2024
Tickers
CYTK
From Benzinga
From Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.